Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with 1-year IDeg/Asp Therapy in Poorly Controlled and Non-compliant Patients
2021 ◽
Vol 0
(0)
◽
pp. 0-0
Keyword(s):
2019 ◽
Vol 21
(6)
◽
pp. 329-335
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 96
(1)
◽
pp. 175-180
◽